Betteromics
Betteromics is a digital medicine pioneer that enables scientists, researchers, and clinicians to understand and gain insights from massive amounts of data using advanced computation and AI techniques. The company’s Omics AI Cloud streamlines the creation of knowledge graphs, integrating and connecting data with emerging standards and ontologies from disparate silos. The platform’s built-in compliance standards allow clients to operate their data knowing there are rigorous protocols in place for their most valuable and sensitive data assets.
Sector
Digital Medicine
Strategy
Digital Medicine
Status
Active
Website
betteromics.com
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.